SEC Form 4 · accession 0001720626-17-000002
Adhera Therapeutics, Inc. · ATRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter D. Weinstein
Officer — Chief Legal Officer
Period of report
Oct 12, 2017
Accepted (ET)
Oct 24, 2017 · 1:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000737207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $2.40 | Oct 12, 2017 | A | 60,000 | A | Oct 12, 2018 | Oct 12, 2022 | common stock | 60,000 | 60,000 | D |